225 related articles for article (PubMed ID: 31904665)
21. Haematological classification of the chronic myeloid leukaemias.
Shepherd PC; Ganesan TS; Galton DA
Baillieres Clin Haematol; 1987 Dec; 1(4):887-906. PubMed ID: 3332855
[TBL] [Abstract][Full Text] [Related]
22. A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant
Gao T; Yu C; Xia S; Liang T; Gu X; Liu Z
Ther Adv Hematol; 2020; 11():2040620720927105. PubMed ID: 32782768
[TBL] [Abstract][Full Text] [Related]
23. Myelodysplastic/myeloproliferative neoplasms.
Cazzola M; Malcovati L; Invernizzi R
Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.
Hochman MJ; Smith BD; Karantanos T; Braunstein EM; Gojo I; Jain T; Streiff MB; Moliterno AR; DeZern AE
Int J Hematol; 2023 Mar; 117(3):456-462. PubMed ID: 36181657
[TBL] [Abstract][Full Text] [Related]
25. Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review.
Belkhair J; Raissi A; Elyahyaoui H; Ameur MA; Chakour M
Leuk Res Rep; 2019; 12():100172. PubMed ID: 31194134
[TBL] [Abstract][Full Text] [Related]
26. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Talati C; Padron E
Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
Kvasnicka HM
Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
[TBL] [Abstract][Full Text] [Related]
29. Solving the Puzzle: The Diagnosis of Atypical Chronic Myeloid Leukemia, BCR-ABL1-Negative (aCML).
Danyal K; Devitt K; Gardner JA
J Assoc Genet Technol; 2021; 47(3):127-131. PubMed ID: 34491231
[TBL] [Abstract][Full Text] [Related]
30. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
31. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
Orazi A; Germing U
Leukemia; 2008 Jul; 22(7):1308-19. PubMed ID: 18480833
[TBL] [Abstract][Full Text] [Related]
32. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT; Tyner JW; Gotlib J
Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
[TBL] [Abstract][Full Text] [Related]
33. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
34. Advances in myelodysplastic/myeloproliferative neoplasms.
Prakash S; Arber DA; Bueso-Ramos C; Hasserjian RP; Orazi A
Virchows Arch; 2023 Jan; 482(1):69-83. PubMed ID: 36469102
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.
Fontana D; Elli EM; Pagni F; Piazza R
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of neutrophilic myeloid neoplasms.
Schwede M; Gotlib J; Shomali W
Clin Adv Hematol Oncol; 2021 Jul; 19(7):450-459. PubMed ID: 34236344
[TBL] [Abstract][Full Text] [Related]
37. Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T; Medeiros LJ; Hu S
Curr Hematol Malig Rep; 2018 Dec; 13(6):435-445. PubMed ID: 30370478
[TBL] [Abstract][Full Text] [Related]
38. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
39. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
Tiu RV; Sekeres MA
Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
[TBL] [Abstract][Full Text] [Related]
40. Pathology of the myeloproliferative diseases.
George TI; Arber DA
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1101-27. PubMed ID: 14560777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]